finney.biz
Finney Capital: Portfolio
http://finney.biz/biz/portfolio.html
MJ Research, Inc. (Including MJ Bioworks and MJ Geneworks) 1986 - 2004; board seat 1986-2004. Developed, manufactured, and sold instruments and reagents for use in life science research. At the time it was acquired by Bio-Rad Laboratories in 2004, it was privately held and had annualized sales of approximately $90 million. 1996 - 2008; board seat 1996-2008. Import, manufacture, and sale of biotechnology products in Australia and New Zealand. Exit: Management buyout. Orion Genomics, LLC. Sage Science, Inc.
lifescienceangels.com
Portfolio - Life Science Angels
http://lifescienceangels.com/portfolio
High quality, low-cost terpene products for the flavor and fragrance, food ingredient, pharmaceutical, agricultural and biofuel markets. Acquired by Evolva in 2014. Improving maternal and fetal health through the development of a highly accurate, serum-based diagnostic test for preeclampsia. Acquired by Progenity in 2015. Drug-coated balloon platforms for the touch-and-go treatment of vascular diseases. Acquired by Covidien in 2013. Wearable textile sensors for use in fitness and health monitoring, while...
pharmapositionveille.blogspot.com
Veille Pharma-Santé sur Internet: mars 2012
http://pharmapositionveille.blogspot.com/2012_03_01_archive.html
Veille Pharma-Santé sur Internet. Veille Stratégique sur Internet pour l'Industrie Pharmaceutique. Moteur de Recherche de Veille Concurrentielle pour l'Industrie Pharmaceutique et de Santé. Vidéo : Si cest écrit, cest vrai? France Brevets : fonds dinvestissement français s. Vidéo des États Généraux de lIntelligence Économi. Analyse mondiale de Thomson Reuters sur la proprié. Document de référence : Intelligence économique, c. Dernières Mises à jour de PharmaPosition.net, Mote. Jeudi 29 mars 2012. 24 juin...
finneycapital.com
Finney Capital: Portfolio
http://www.finneycapital.com/portfolio.html
MJ Research, Inc. (Including MJ Bioworks and MJ Geneworks) 1986 - 2004; board seat 1986-2004. Developed, manufactured, and sold instruments and reagents for use in life science research. At the time it was acquired by Bio-Rad Laboratories in 2004, it was privately held and had annualized sales of approximately $90 million. 1996 - 2008; board seat 1996-2008. Import, manufacture, and sale of biotechnology products in Australia and New Zealand. Exit: Management buyout. Orion Genomics, LLC. Sage Science, Inc.
westshoremg.com
West Shore Management Group | Leadership for Challenging Economic Times
http://www.westshoremg.com/WSAPP/V/bio.html
Jim Olson, Founder and CEO - WestShore Management Group. Jim Olson founded the WestShore Management Group in April of 2007, continuing a distinguished career after leading several high technology businesses for two Fortune companies and serving for nine years as CEO of SkyStream Networks, the top rated IPTV video head-end provider worldwide. WestShore Management Group provides Interim CEO, corporate consulting, and executive development services for both public, and private, venture-financed companies.